Tag: Achaogen

December 16, 2018

5 Top Weekly NASDAQ Biotech Stocks: Innovate Leads the Pack

Innovate Biopharmaceuticals, Aridis Pharmaceuticals, Imprimis Pharmaceuticals, Achaogen and SynthoRx were last week's top gainers.
November 7, 2018

Achaogen Plans to Restructure, Again

The restructuring is expected to reduce operating expenses by 35 to 40 percent — aside from one-time charges — and...
August 3, 2018

CMS Grants New Technology Add-on Payment to ZEMDRI (plazomicin)

Achaogen (NASDAQ:AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) gram-negative infections, today...
June 27, 2018

Achaogen’s Share Price Dips Following FDA Approval

The company announced on Tuesday (June 26) it received news from the FDA for its drug Zemdri (plazomicin) was approved...
June 26, 2018

ZEMDRITM (plazomicin) Approved by FDA for the Treatment of Adults with Complicated Urinary Tract Infections

Achaogen (NASDAQ:AKAO), a biopharmaceutical company developing and commercializing innovative antibacterial agents to address multidrug resistant (MDR) gram-negative infections, today announced...